0.5959
前日終値:
$0.6471
開ける:
$0.63
24時間の取引高:
194.43K
Relative Volume:
2.06
時価総額:
$46.12M
収益:
$234.00K
当期純損益:
$-23.11M
株価収益率:
-0.579
EPS:
-1.0292
ネットキャッシュフロー:
$-20.71M
1週間 パフォーマンス:
-7.57%
1か月 パフォーマンス:
-16.70%
6か月 パフォーマンス:
-13.42%
1年 パフォーマンス:
-25.49%
Envoy Medical Inc Stock (COCH) Company Profile
名前
Envoy Medical Inc
セクター
電話
651-361-8000
住所
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
COCH
Envoy Medical Inc
|
0.5959 | 46.12M | 234.00K | -23.11M | -20.71M | -1.0292 |
|
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-10-06 | 開始されました | Lake Street | Buy |
| 2026-03-31 | 開始されました | H.C. Wainwright | Buy |
| 2024-06-24 | 開始されました | Ascendiant Capital Markets | Buy |
Envoy Medical Inc (COCH) 最新ニュース
Envoy Medical announces 1-for-10 reverse stock split By Investing.com - Investing.com UK
Envoy Medical Announces Reverse Stock Split - Yahoo Finance
A 1-for-10 split is intended to help Envoy Medical meet Nasdaq’s $1 minimum bid requirement. - Stock Titan
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design - TMX Newsfile
A surgeon joining P3 Health Partners gets an option to buy 110,000 shares. - Stock Titan
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant - www.marketscreener.com
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio - TMX Newsfile
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio - Yahoo Finance
A hearing-device maker adds two patents, bringing its global total to 97 - Stock Titan
Alta Partners reports 2.1M Envoy Medical (COCH) shares - stocktitan.net
Enterprise value to EBIT forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
COCH News | ENVOY MEDICAL INC (NASDAQ:COCH) - ChartMill
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical CEO to present fully implanted he... - Pluang
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th - Yahoo Finance
Envoy Medical CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference in September 2026 - kalkine.ca
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th - TMX Newsfile
Envoy Medical Inc. (NASDAQ: COCH) Share Price, COCH Stock News, COCH Share Price & Updates - kalkine.ca
Envoy Medical (NASDAQ: COCH) weighs 1‑for‑25 reverse split to avoid delisting - Stock Titan
Envoy Medical Inc (COCH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Envoy Medical names Robert Potashnick Chief Accounting Officer and VP of Finance - TradingView
Envoy Medical (COCH) awards 250K options to Potashnick - stocktitan.net
Are Medical Stocks Lagging Compugen (CGEN) This Year? - Yahoo Finance
HC Wainwright Cuts Envoy Medical (NASDAQ:COCH) Price Target to $2.00 - MarketBeat
H.C. Wainwright cuts Envoy Medical stock price target on share count - Investing.com Canada
H.C. Wainwright cuts Envoy Medical stock price target on share count - Investing.com UK
COCH Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Envoy (COCH) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Price Move - vinanet.vn
Envoy (COCH) Q1 2026 Earnings: The Bottom-Line Figure Beats Its Comparison for the Current Session - vinanet.vn
Envoy (COCHW) Momentum: Trades in a Narrow Directional Range at $0.05 at the Close - vinanet.vn
Envoy Medical Warrant (COCHW) Holds at $0.05 as Flat Trading PersistsBullish Percent Index - Vinanet
Envoy Medical Warrant (COCHW) Holds at $0.05 as Flat Trading PersistsVolume Breakout Ideas - dars.gov.et
Price to sales forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street Its The Platformsinvestor distribution. - ACCESS Newswire
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA - Caledonian Record
The Beat: Target names AI chief, Niron gets White House backing, Envoy chases cochlear market - The Business Journals
Envoy Medical’s Limited Disclosures Put Spotlight on 10-K Risk Factors for Investors - TipRanks
Envoy Medical earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Envoy Medical earnings beat, revenue fell short of estimates - Investing.com
Envoy Medical (NASDAQ: COCH) raises cash, advances fully implanted cochlear implant - Stock Titan
Envoy Medical Releases Q2 2026 Financial Results - AlphaStreet
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Envoy Medical (NASDAQ:COCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Envoy Medical Q2 Results: EPS beats estimate, sales miss - scanx.trade
Envoy Medical, Inc. Q2 2026: Revenue $51K, Net loss $5982K — 10-Q Summary - TradingView
Envoy Medical (NASDAQ: COCH) burns cash on Acclaim implant trial after $28M raise - Stock Titan
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones - newsfilecorp.com
Envoy Medical (COCH) Reports Q2 2026 Results, Submits First FDA PMA Module and Posts Strong Acclaim® Cochlear Implant Clinical Data - kalkine.ca
Envoy Medical Inc (COCH) 財務データ
収益
当期純利益
現金流量
EPS
Envoy Medical Inc (COCH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
大文字化:
|
ボリューム (24 時間):